secwatch.observer — SEC 8-K summary
======================================

Issuer:     PURE BIOSCIENCE, INC. (PURE)
CIK:        0001006028
Form:       8-K
Filed at:   2025-03-17T23:59:59+00:00
Accession:  0001493152-25-010568
Event type: earnings
Sentiment:  negative
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PURE Bioscience Q2 net sales up 20% YoY to $391K; net loss narrows to $798K
---------------------------------------------------------------------------

- Net product sales $391K for fiscal Q2 ended Jan 31, 2025, vs $325K a year ago (+20%).
- Net loss $798K vs $1,002K in prior-year quarter; loss per share unchanged at ($0.01).
- SG&A expenses fell $194K due to reductions in personnel, professional fees, and stock comp.
- Company advanced dairy membrane solutions to full-scale in-plant pilots with a large distribution partner.
- Pilot data shows benefits in water/energy savings, fouling removal, and reduced downtime for dairy ops.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1006028/000149315225010568/0001493152-25-010568-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1006028/000149315225010568/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-010568

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer